The influence of food on the pharmacokinetics of piperaquine in healthy Vietnamese volunteers

被引:28
作者
Hai, Trinh Ngoc [2 ]
Hietala, Sofia Friberg [1 ]
Huong, Nguyen Van [2 ]
Ashton, Michael [1 ]
机构
[1] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Unit Pharmacokinet & Drug Metab, Box 431, S-40530 Gothenburg, Sweden
[2] NIMPE, Dept Malaria Treatment & Res, Pharmaceut Unit, Hanoi, Vietnam
关键词
malaria; piperaquine; food-drug interactions; pharmacokinetics;
D O I
10.1016/j.actatropica.2008.05.013
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
The combination piperaquine and dihydroartemisinin is emerging as first line treatment of uncomplicated falciparum malaria in Southeast Asia. The aim of this study was to determine the influence of a standard Vietnamese meal on the single-dose pharmacokinetics of piperaquine when administered in combination with dihydroartemisinin, and to gain extended data on the terminal half-life of piperaquine in healthy Vietnamese volunteers. Subjects were randomly assigned to take a single oral dose of piperaquine phosphate (640 mg) + dihydroartemisinin (80 mg) together with a standardized Vietnamese meal (n = 16) or to remain fasting for 4 h following drug intake (n = 16). Frequent blood sampling was conducted during 36 h, followed by weekly samples for 7 weeks. The pharmacokinetic parameters of piperaquine were determined by noncompartmental analysis. The median (80% central range) AUC(0-last) was 11.5 (6.9-17.3) h mg/L in fed and 13.9 (2.8-19.3) h mg/L in fasting subjects, indicating a considerable variability in exposure in both groups. The estimated overall oral clearance was 0.27 (0.12-1.49)L/(h kg), the volume of distribution during the terminal elimination phase was 230 (102-419)L/kg and estimated terminal half-life was 18 (5-93) days. This study did not demonstrate a significant impact of a standardized Vietnamese meal on the oral absorption of piperaquine. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:145 / 149
页数:5
相关论文
共 22 条
[1]   Safety, tolerablity, and single- and multiple-dose pharmacokinetics of piperaquine phosphate in healthy subjects [J].
Ahmed, Tausif ;
Sharma, Pradeep ;
Gautam, Anirudh ;
Varshney, Brifesh ;
Kothari, Monica ;
Ganguly, Sanjeev ;
Moehrle, Joerg J. ;
Paliwal, Jyoti ;
Saha, Alilanian ;
Batra, Vijay .
JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 48 (02) :166-175
[2]   A randomized, controlled study of a simple, once-daily regimen of dihydroartemisinin-piperaquine for the treatment of uncomplicated, multidrug-resistant falciparum malaria [J].
Ashley, EA ;
McGready, R ;
Hutagalung, R ;
Phaiphun, L ;
Slight, T ;
Proux, S ;
Thwai, KL ;
Barends, M ;
Looareesuwan, S ;
White, NJ ;
Nosten, F .
CLINICAL INFECTIOUS DISEASES, 2005, 41 (04) :425-432
[3]   Efficacy and safety of dihydroartemisinin-piperaquine (Artekin) in Cambodian children and adults with uncomplicated falciparum malaria [J].
Denis, MB ;
Davis, TME ;
Hewitt, S ;
Incardona, S ;
Nimol, K ;
Fandeur, T ;
Poravuth, Y ;
Lim, C ;
Socheat, D .
CLINICAL INFECTIOUS DISEASES, 2002, 35 (12) :1469-1476
[4]   Dihydroartemisinin-piperaquine versus artesunate-amodiaquine:: Superior efficacy and posttreatment prophylaxis against multidrug-resistant Plasmodium falciparum and Plasmodium vivax malaria [J].
Hasugian, A. R. ;
Purba, H. L. E. ;
Kenangalem, E. ;
Wuwung, R. M. ;
Ebsworth, E. P. ;
Maristela, R. ;
Penttinen, P. M. P. ;
Laihad, F. ;
Anstey, N. M. ;
Tjitra, E. ;
Price, R. N. .
CLINICAL INFECTIOUS DISEASES, 2007, 44 (08) :1067-1074
[5]   Dihydroartemisinin-piperaquine against multidrug-resistant Plasmodium falciparum malaria in Vietnam:: randomised clinical trial [J].
Hien, TT ;
Dolecek, C ;
Mai, PP ;
Dung, NT ;
Truong, NT ;
Thai, LH ;
An, DTH ;
Thanh, TT ;
Stepniewska, K ;
White, NJ ;
Farrar, J .
LANCET, 2004, 363 (9402) :18-22
[6]  
Hung TY, 2004, BRIT J CLIN PHARMACO, V57, P253, DOI [10.1046/j.1365-2125.2003.02004.x, 10.1111/j.1365-2125.2003.02004.x]
[7]   Safety evaluation of fixed combination piperaquine plus dihydroartemisinin (Artekin®) in Cambodian children and adults with malaria [J].
Karunajeewa, H ;
Lim, C ;
Hung, TY ;
Ilett, KF ;
Denis, MB ;
Socheat, D ;
Davis, TME .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 57 (01) :93-99
[8]   Pharmacokinetics and efficacy of piperaquine and chloroquine in melanesian children with uncomplicated malaria [J].
Karunajeewa, Harin A. ;
Ilett, Kenneth F. ;
Mueller, Ivo ;
Siba, Peter ;
Law, Irwin ;
Page-Sharp, Madhu ;
Lin, Enmoore ;
Lammey, Jovitha ;
Batty, Kevin T. ;
Davis, Timothy M. E. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (01) :237-243
[9]   High throughput assay for the determination of piperaquine in plasma [J].
Lindegårdh, N ;
White, NJ ;
Day, NPJ .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2005, 39 (3-4) :601-605
[10]   Pharmacokinetics of piperaquine after single and multiple oral administrations in healthy volunteers [J].
Liu, Changhui ;
Zhang, Rong ;
Hong, Xin ;
Huang, Tianlai ;
Mi, Suiqing ;
Wang, Ningsheng .
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2007, 127 (10) :1709-1714